Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 51 of 55 for:    hki-272 OR neratinib

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03101748
Recruitment Status : Recruiting
First Posted : April 5, 2017
Last Update Posted : July 3, 2019
Sponsor:
Collaborators:
National Cancer Institute (NCI)
Puma Biotechnology, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 1, 2026
Estimated Study Completion Date : January 1, 2026